Astrocytoma Treatment & Management: Approach Considerations, Surgical Care, Medical Care
Current therapeutic approaches to diffuse grade II and III gliomas - Alberto Picca, Giulia Berzero, Marc Sanson, 2018
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy
A Prognostic Model Based on Preoperative MRI Predicts Overall Survival in Patients with Diffuse Gliomas | American Journal of Neuroradiology
Predicting overall survival in diffuse glioma from the presurgical connectome | Scientific Reports
.jpg "Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery")
Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution Iran 2001-2010 - Iranian Journal of Neurosurgery
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients | Radiation Oncology | Full Text
Extent of resection and molecular pathologic subtype are potent prognostic factors of adult WHO grade II glioma | Scientific Reports
Kaplan-Meier overall survival of spinal cord astrocytoma by grade.... | Download Scientific Diagram
Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology in: Journal of Neurosurgery Volume 119 Issue 2 (2013) Journals
Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas | SpringerLink
Astrocytoma progression scoring system based on the WHO 2016 criteria | Scientific Reports
Kaplan–Meier survival curves for all lower-grade glioma and WHO 2016... | Download Scientific Diagram
Kaplan–Meier survival curves for WHO grade II to III diffuse glioma... | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
Overall survival of patients with diffuse astrocytomas. The presence of... | Download Scientific Diagram
Overall survival among IDH-mutated diffuse gliomas (n = 475) stratified... | Download Scientific Diagram
Advantages of gross total resection in patients with astrocytoma: A population‑based study
Spotlights on adult patients with pediatric-type diffuse gliomas in accordance with the 2021 WHO classification of CNS tumors - Frontiers
Risk factors for early progression of diffuse low-grade glioma in adults | Chinese Neurosurgical Journal
Frontiers Publishing Partnerships | Isocitrate Dehydrogenase IDH1 and IDH2 Mutations in Human Cancer: Prognostic Implications for Gliomas
Frontiers | Prognostic Factors Associated With Survival in Patients With Diffuse Astrocytoma
